Grant and Research Support

GRANT AND RESEARCH SUPPORT

Discover
HEMA Biologics

Apply For Grant and Research Support

Thank you for your interest in Hema Biologics. Below, find the guidelines for submitting medical education grant and investigator-initiated trial proposals.

If you have questions regarding funding for medical fellowships/scholarships or Investigator-Initiated Trials (IITs), please first contact our Medical Affairs Department at grants@hemabio.com.

Medical Education Grants Proposal

What is this?

As part of our goal to help those living with the rarest bleeding disorders, we are strongly committed to supporting independent medical education activities.

Requirements for submission:

Download List of Required Documentation (.pdf)

How to submit application:
Completed educational grant request applications should be sent electronically to our Medical Affairs Department grants@hemabio.com.

Investigator-Initiated Research Proposal

What is this?

Key scientific insights often come from clinical settings where the full spectrum of disease is manifest. Providing support for clinical scientists performing unsolicited, independent research projects is part of our commitment to helping those with the rarest bleeding disorders.

Requirements for submission:

Download HEMA IIR Proposal Form (.pdf)

Download list of Required Documentation (.pdf)

How to submit application:
Email all required documents to grants@hemabio.com or mail them in one package to:

HEMA Biologics, LLC.
c/o Senior Medical Director, Medical Affairs
4441 Springdale Road
Louisville, KY 40241
855-718-HEMA (4362)

General Guidelines for Medical Educational Grant Requests and Investigator-Initiated Research Proposals

HEMA Biologics will acknowledge the receipt of all requests and proposals within 5 business days. If you have not heard from HEMA Biologics within this time frame, do not hesitate to contact Medical Affairs at 855-718-HEMA (4362).

Support by Hema Biologics of independent educational activities is limited to only those that fall within the company's specific area of therapeutic focus, to treat the rarest bleeding disorders.

Only fully-completed educational grant applications and investigator-initiated research proposals will be reviewed, and completing the application does not guarantee approval nor financial support in the entire amount being requested.

The contact person at the requesting organization will be notified within 3 months of receipt of the application with the approval or denial status. Therefore, it is recommended that funding requests be submitted at least 3 months prior to the date of the event, as applicable, to ensure sufficient time for internal review.

If Hema Biologics is able to provide funding for the educational activity, a Letter of Agreement (provided by Hema Biologics) must be signed by the Educational Provider and Hema Biologics.

Any activity for which a grant or investigator-initiated research proposal is awarded is required to be compliant with and adhere to federal and state guidelines and regulations, including, but not limited to, the FDA Final Guidance on Industry-Supported Scientific and Educational Activities, the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, the American Medical Association (AMA) Ethical Guidelines for Gifts to Physicians from Industry, and the Pharmaceutical Research and Manufacturers of America (PhRMA) Code on Interactions with Healthcare Professionals, where applicable.